Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Alessandra D'Addio"'
Autor:
Francesca Palandri, Elena M. Elli, Giuseppe Auteri, Massimiliano Bonifacio, Giulia Benevolo, Florian H. Heidel, Simona Paglia, Malgorzata M. Trawinska, Costanza Bosi, Elena Rossi, Mario Tiribelli, Alessia Tieghi, Alessandra Iurlo, Nicola Polverelli, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Eloise Beggiato, Daniela Cilloni, Caterina Tatarelli, Francesco Mendicino, Maurizio Miglino, Monica Bocchia, Monica Crugnola, Camilla Mazzoni, Andrea D. Romagnoli, Giovanni Rindone, Sara Ceglie, Alessandra D’Addio, Eleonora Santoni, Daniele Cattaneo, Daniela Bartoletti, Roberto M. Lemoli, Mauro Krampera, Antonio Cuneo, Gianpietro C. Semenzato, Roberto Latagliata, Elisabetta Abruzzese, Nicola Vianelli, Michele Cavo, Alessandro Andriani, Valerio De Stefano, Giuseppe A. Palumbo, Massimo Breccia
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-5 (2023)
Externí odkaz:
https://doaj.org/article/142637191ad84c61a603c3e424c76be2
Autor:
Roberto M. Lemoli, Alessandra D’Addio
Publikováno v:
Haematologica, Vol 93, Iss 3 (2008)
Externí odkaz:
https://doaj.org/article/7044ad56a4494aa1a0e27008b41f5271
Autor:
Roberto M Lemoli, Alessandra D'Addio
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 33, Iss 3, Pp 172-173 (2011)
Externí odkaz:
https://doaj.org/article/89afaa20be12483e85405afa5162bae6
Autor:
Alessia Tieghi, Alessandra D'Addio, Florian H. Heidel, Roberto Latagliata, Elisa Bossi, Francesco Cavazzini, Giulia Benevolo, Nicola Vianelli, Michele Cavo, Roberto M. Lemoli, Mauro Krampera, Massimo Breccia, Massimiliano Bonifacio, Gianni Binotto, Antonio Cuneo, Giovanni Caocci, Daniela Bartoletti, Mario Tiribelli, Ida Carmosino, Lucia Catani, Giuseppe Auteri, Francesco Lanza, Giuseppe A. Palumbo, Nicola Polverelli, Francesca Palandri, Micaela Bergamaschi, Monica Crugnola, Elena Maria Elli
Publikováno v:
Hematological Oncology. 39:409-418
In 816 patients with 2016 World Health Organization-defined polycythemia vera (PV) enrolled in a multicenter retrospective study, we investigated the predictive value of Charlson comorbidity index (CCI) and body mass index (BMI) on thrombosis, progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3939263de47b0f932025c0ddc18dfc
https://doi.org/10.1002/hon.2843
https://doi.org/10.1002/hon.2843
Autor:
Nicola Vianelli, Francesca Palandri, Giulia Benevolo, Giuseppe A. Palumbo, Antonio Cuneo, Mauro Krampera, Alessandra D'Addio, Florian H. Heidel, Massimo Breccia, Daniela Bartoletti, Monica Crugnola, Gianni Binotto, Alessia Tieghi, F. Cavazzini, Ida Carmosino, Micaela Bergamaschi, Michele Cavo, Giovanni Caocci, Francesco Lanza, Roberto M. Lemoli, Massimiliano Bonifacio, Giuseppe Auteri, Elisa Bossi, Elena Maria Elli, Mario Tiribelli, Lucia Catani, Roberto Latagliata, Nicola Polverelli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33db9556d9fa6a5e27888e8e02798f5
https://doi.org/10.1002/hon.2843/v3/response1
https://doi.org/10.1002/hon.2843/v3/response1
Autor:
Massimiliano Bonifacio, Elena Maria Elli, Giuseppe Auteri, Giovanni Caocci, Daniela Bartoletti, Francesco Mendicino, Roberto Latagliata, Giulia Benevolo, Francesco Cavazzini, Novella Pugliese, Mario Tiribelli, Elena Rossi, Massimo Breccia, Monica Crugnola, Valerio De Stefano, Bruno Martino, Ambra Di Veroli, Francesca Palandri, Nicola Vianelli, Alessandro Andriani, Alessandra D'Addio, Florian H. Heidel, Giuseppe A. Palumbo, Michele Cavo, Alessia Tieghi, Gianni Binotto
Publikováno v:
Blood. 138:2581-2581
Introduction: Ruxolitinib (Rux) has been recently approved as second-line therapy in patients (pts) with Polycythemia Vera (PV) resistant/intolerant to hydroxyurea (HU). Median age of PV pts enrolled in the pivotal Response trials was around 60 yrs;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17955546cc4312651312ffa1323a63a4
https://doi.org/10.1182/blood-2021-149612
https://doi.org/10.1182/blood-2021-149612
Autor:
Enrica Antonia Martino, Antonio Cuneo, Fabrizio Pane, Luigi Scaffidi, Giuseppe Auteri, Michele Cavo, Bruno Martino, Roberto Latagliata, Alessia Tieghi, Francesco Cavazzini, Gianpietro Semenzato, Rossella Stella, Monica Crugnola, Francesco Mendicino, Novella Pugliese, Nicola Polverelli, Mauro Krampera, Roberto M. Lemoli, Massimiliano Bonifacio, Daniela Bartoletti, Giuseppe A. Palumbo, Mario Tiribelli, Nicola Vianelli, Lucia Catani, Elena Maria Elli, Alessandra D'Addio, Gianni Binotto, Francesca Palandri, Fabio D'Amore, Massimo Breccia, Simona Tomassetti, Florian H. Heidel, Giovanni Caocci, Giulia Benevolo
Publikováno v:
Blood. 136:17-18
Introduction: Hydroxyurea (HU) is the most used cytoreductive therapy (tx) for patients (pts) with polycythemia vera (PV). However, many pts may have suboptimal responses (SubOR) and/or toxicity (TOX) to HU. After HU, Ruxolitinib (RUX) may achieve he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::130b32c6a94465e8a28fa2c71241ea30
https://doi.org/10.1182/blood-2020-140001
https://doi.org/10.1182/blood-2020-140001
Autor:
Francesco Mendicino, Massimo Breccia, Mauro Krampera, Mario Tiribelli, Lucia Catani, Bruno Martino, Massimiliano Bonifacio, Alessandra D'Addio, Alessia Tieghi, Daniela Bartoletti, Gianni Binotto, Ambra Di Veroli, Enrica Antonia Martino, Florian H. Heidel, Elena Maria Elli, Giovanni Caocci, Gianpietro Semenzato, Michele Cavo, Fabrizio Pane, Roberto Latagliata, Simona Tomassetti, Francesco Cavazzini, Giuseppe A. Palumbo, Giulia Benevolo, Novella Pugliese, Luigi Scaffidi, Antonio Cuneo, Francesca Palandri, Fabio D'Amore, Nicola Polverelli, Monica Crugnola, Roberto M. Lemoli, Rossella Stella, Nicola Vianelli, Giuseppe Auteri
Publikováno v:
Blood. 136:43-44
Introduction Hydroxyurea (HU) is worldwide used in the current clinical practice as first line treatment in high risk patients with Polycythemia Vera (PV). However, its efficacy has been seldom evaluated in the real-life setting. Aims The present stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3282ed661704345bfb1e2026fb87d889
https://doi.org/10.1182/blood-2020-140810
https://doi.org/10.1182/blood-2020-140810
Autor:
Daniela Bartoletti, Giuseppe A. Palumbo, Davide Griguolo, Massimo Breccia, Massimiliano Bonifacio, Nicola Polverelli, Francesca Palandri, Roberto M. Lemoli, Antonio Cuneo, Micaela Bergamaschi, Giovanni Caocci, Gianpietro Semenzato, Francesco Lanza, Gianni Binotto, Alessandra D'Addio, Elisa Diral, Alessia Tieghi, Emanuele Sutto, Monica Crugnola, Elena Maria Elli, Ida Carmosino, Mario Tiribelli, Florian H. Heidel, Lucia Catani, Mauro Krampera, Michele Cavo, Giulia Benevolo, Roberto Latagliata, Francesco Cavazzini, Eloise Beggiato, Katia Codeluppi, Nicola Vianelli, Giuseppe Auteri
Publikováno v:
Blood. 134:4184-4184
Introduction: Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by excessive red cell production and release of pro-inflammatory cytokines resulting in increased thrombotic risk, presence of systemic symptoms and reduced overall s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11c27a7ab1d5e564e19e85243e1614d3
https://doi.org/10.1182/blood-2019-125387
https://doi.org/10.1182/blood-2019-125387
Autor:
Mario Tiribelli, Lucia Catani, Alessandra D'Addio, Elisa Diral, Francesca Palandri, Daniela Bartoletti, Nicola Vianelli, Antonio Cuneo, Uros Markovic, Elena Maria Elli, Gianpietro Semenzato, Roberto M. Lemoli, Micaela Bergamaschi, Davide Griguolo, Massimiliano Bonifacio, Giuseppe A. Palumbo, Michele Cavo, Alessia Tieghi, Francesco Lanza, Monica Crugnola, Massimo Breccia, Luigi Scaffidi, Giuseppe Auteri, Nicola Polverelli, Mauro Krampera, Katia Codeluppi, Gianni Binotto, Giovanni Caocci, Christian Di Pietro, Florian H. Heidel, Giulia Benevolo, Roberto Latagliata, Francesco Cavazzini
Publikováno v:
Blood. 134:4174-4174
Introduction: Hydroxyurea (HU) is the recommended treatment in patients (pts) with polycythemia vera (PV) at high thrombotic risk. In 2013, European LeukemiaNet (ELN) guidelines defined criteria for response to HU including hematology and clinical pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb0f4cb4665e2501739735320cac20e
https://doi.org/10.1182/blood-2019-125388
https://doi.org/10.1182/blood-2019-125388